LifeMD
 | This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (October 2024) |
| LFMD | |
| Formerly | ImmuDyne, Inc. Conversion Labs, Inc. |
| Company type | Public |
| Industry | Telehealth |
| Founded | May 24, 1994 in New York City, United States |
Key people | Justin Schreiber, CEO Bobby Jindal, Board member[1] |
| Website | lifemd |
| Footnotes / references [2] | |
LifeMD, Inc. is a publicly traded American telehealth company.[3] It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications.[4]
The company was founded as ImmuDyne, Inc. in 1994 and completed its initial public offering in 2001.[5] In 2018, it rebranded as Conversion Labs, Inc. with Justin Schreiber named chief executive officer.[6] The company changed its name to LifeMD in 2020 and started using the ticker name LFMD.[7][8]
In June 2023, LifeMD announced a weight management program to prescribe GLP-1 medications upon meeting requirements in a virtual appointment with a clinician.[9] It began a pilot program with Medifast, which later announced a partnership between the companies to connect each other's customers. LifeMD also received a $20 million investment from Medifast at that time.[10]
The company introduced private health insurance acceptance in 2024.[11]
References
[edit]- ^ Schwartz, Noah (20 September 2022). "LifeMD adds former governor Bobby Jindal to board of directors". Becker's Hospital Review. Retrieved 2 October 2024.
- ^ "LFMDP (U.S.: Nasdaq)". The Wall Street Journal. Retrieved 2 October 2024.
- ^ Dattilo, Emily (13 December 2023). "LifeMD Stock Pops on Medifast Agreement. It's All About Weight-Loss Drugs". Barron's. Retrieved 2 October 2024.
- ^ Petersen, Andrea (13 December 2023). "Diet Company Medifast, Once an Ozempic Skeptic, Embraces Weight-Loss Drugs With New Deal". The Wall Street Journal. Retrieved 2 October 2024.
- ^ Hagen, Jessica (21 September 2023). "LifeMD partners with pharma company for direct-to-consumer hormone therapy". Mobi Health News. Retrieved 2 October 2024.
- ^ "Conversion Labs Reports 89% Increase in Preliminary Revenues During Second Quarter 2018". Business Insider. 11 July 2018. Retrieved 2 October 2024.
- ^ "Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD". Yahoo! Finance. 22 February 2021. Retrieved 2 October 2024.
- ^ "Conversion Labs, Inc. (CVLB)". Stock News. Retrieved 2 October 2024.
- ^ Plescia, Marissa (28 June 2023). "LifeMD Launches GLP-1 Weight Management Program". MedCity News. Retrieved 2 October 2024.
- ^ "LifeMD Agrees To Partner With Medifast For Weight Management Solutions, LifeMD Up In Pre-market". Business Insider. 13 December 2023. Retrieved 2 October 2024.
- ^ Bricchi, Brando (25 June 2024). "LifeMD expands insurance coverage for virtual care". Investing.com.